| Literature DB >> 30157437 |
Agnieszka Tudek1, Manfred Schmid1, Marius Makaras1, J David Barrass2, Jean D Beggs2, Torben Heick Jensen3.
Abstract
Genomes are promiscuously transcribed, necessitating mechanisms that facilitate the sorting of RNA for function or destruction. The polyA (pA) tail is one such distinguishing feature, which in the Saccharomyces cerevisiae nucleus is bound by the Nab2p protein, yielding transcript protection. As Nab2p also contacts the main nuclear export factor Mex67p, we asked whether transport kinetics contributes to RNA sorting. Indeed, 3' end sequencing of newly transcribed pA+ RNAs demonstrates that nuclear depletion of Mex67p elicits their instant and global decay. A similar phenotype is evident upon inactivation of other export factors and proportional to the amount of nuclear pA+ RNA. As RNA expression is partially rescued by Nab2p overexpression, we propose that an export block out-titrates Nab2p onto nuclear-retained pA+ RNA, reducing the pool of Nab2p available to protect new transcripts. More generally, we suggest that nuclear RNA decay, negotiated by Nab2p availability, aids in balancing cellular transcript supply with demand.Entities:
Keywords: Mex67p; Nab2p; nuclear degradation of pA(+) RNA; nuclear export of pA(+) RNA; transcription
Mesh:
Substances:
Year: 2018 PMID: 30157437 PMCID: PMC6130047 DOI: 10.1016/j.celrep.2018.07.103
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423
Figure 1Rapid Nuclear Depletion of Mex67p Results in Global Inhibition of pA+ RNA Net Production
(A) Fluorescent in situ hybridization (FISH) analysis of pA+ RNA using a Cy3-labeled dT18 DNA/LNA probe on fixed WT, Nab2-AA, or Mex67-AA cells subjected to rapamycin treatment for 15 min at 30°C (top). FISH Cy3 images were adjusted to a common display range (defined as the highest and lowest pixel values for the three images) to allow comparison between strain phenotypes. DAPI staining was used to visualize chromatin-rich regions of cell nuclei (bottom).
(B) Schematic workflow of the pA+ RNA 3′ end sequencing experiment. Mex67-AA and Nab2-AA cultures were treated with 4tU for 10 min (“Control (0min)”) or pre-treated with rapamycin for 5 min before 4tU addition (“Depletion (15 min)”). Cells that were not treated with 4tU or rapamycin were used as reference to estimate the background of the 4tU purification (“IP background”). All obtained RNA samples were supplemented with S. pombe spike-in transcripts, biotinylated, and purified on streptavidin beads. Both total and 4tU-purified fractions were subjected to pA+ RNA 3′ end sequencing.
(C) Log2 fold changes (FC) of pA+ RNA net production in 4tU-labeled Mex67-AA (x axis) and Nab2-AA (y axis) cells treated with rapamycin for 15 min and compared with their respective controls (no rapamycin). Three major pA+-containing transcript classes were analyzed: mRNAs, SUTs, and XUTs. Only transcripts purified significantly above background in the control samples are depicted. The number of genes (n), Spearman correlation coefficients (rho), and median (m) values for both datasets are specified on each graph. See also Table S1.
See also Figure S1.
Figure 2Decreased pA+ RNA Net Production in Mex67p- and Nab2p-Depleted Cells Is Due to Increased Transcript Decay
(A) Spearman correlation coefficient matrix comparing mRNA log2 FC of 15/0 min rapamycin ratios in Mex67- and Nab2-AA cells as in Figures 1C and S1C against various estimates of transcription rates. Transcription estimates were derived from RNAPII NET-seq (Churchman and Weissman 2011), RNAPII-CRAC (Milligan et al., 2016), RNAPII-ChIP-seq (Warfield et al., 2017), and RNAPII-ChIP-tiling (Mayer et al., 2010) data.
(B) Schematic workflow of the pA+/pA− RNA 3′ end sequencing experiment. Cells were treated with 4tU for 2 min. In case of the Mex67-AA- and Nab2-AA-depleted cells, cultures were pre-treated with rapamycin for 13 min before 4tU labeling. Addition of S. pombe spike-in RNAs, biotinylation, and purification of 4tU-labeled RNA were done as described in Figure 1B. Samples were then split in two aliquots, in which one was subjected to pA+ RNA 3′ end sequencing as in Figure 1B, and the other was in vitro polyadenylated and rRNA-depleted prior to pA+ RNA 3′ end sequencing.
(C) Genome Browser view of spike-in normalized pA− and pA+ RNA 3′ end reads derived from 2 min 4tU-labeling experiments of untreated (0′) and 15 min nuclear-depleted (15′) Mex67-AA cells, spanning across the gene-coding strand of PGK1 on chromosome III. Annotations below the tracks show genomic A-rich sites masked in the analysis and boundaries of translated and transcribed regions as previously defined in www.yeastgenome.org and Xu et al. (2009), respectively.
(D) Levels of nascent (“pA− (body)”: mean of pA− signal in the region from gene TSS to 200 bp upstream of TES) and mature (“pA+ (3′ end)”: mean of pA+ signal in the region from 200 bp up- and downstream of TES) mRNAs in 2 min 4tU-labeled samples in Mex67-AA (left) and Nab2-AA (right) cells after 0 (red violins) or 15 (blue violins) min of rapamycin treatment. All signals are shown relative to S. pombe spike-ins, with background subtracted, log2 and length scaled. Levels of transcripts that were not purified above background were set to a pseudocount of 10−6. Violin plots shown are overlaid with box plots depicting the median values with boxes demarcating first and third quartiles of the data. See also Table S2.
See also Figure S2.
Figure 3Decreased mRNA Net Production Correlates with the Severity of the Nuclear Export Block
(A) FISH analysis of pA+ RNA as in Figure 1A on fixed WT, Npl3-, Yra1-, Mtr2-, Dbp5-, Mex67-, and Nab2-AA cells subjected to rapamycin for 15 min at 30°C. Images were adjusted and stained with DAPI as in Figure 1A. WT, Mex67-AA, and Nab2-AA cells were from the same experiment shown in Figure 1A.
(B) Quantification of nuclear pA+ RNA signals of AA cells from (A) incubated for 0, 15, 40, or 70 min with rapamycin. Values are shown relative to mean values of non-rapamycin-treated cells and corrected for background. Error bars at individual time points indicate SDs calculated from nuclear pA+ RNA levels of a minimum of 800 cells counted for each strain. Error bars of mean values indicate SDs on the mean accumulation of pA+ RNA over the time course of each protein depletion.
(C) RT-qPCR analysis of selected 4tU RNAs of cells from (A). RNA was harvested after 10 min of 4tU labeling. All values were normalized to S. pombe spike-in, background-subtracted, and displayed relative to respective non-rapamycin-treated samples. Nab2-, Mex67-, Mtr2-, and Dbp5-AA cells were treated with rapamycin for 15 min, whereas Yra1- and Npl3-AA cells were subjected to rapamycin for 30 min to ensure complete nuclear depletion of these proteins. The mean value of all tested RNAs is indicated in red. Error bars indicate SDs from three to nine biological replicates. Error bars on mean values indicate SD from means of all tested transcripts. qPCR results were analyzed using a two-tailed paired t test for the comparisons indicated in the figure (see STAR Methods details for p value thresholds). Mean RNA production rate for Mex67-AA was calculated from nine replicate samples, six of which are depicted in Figure 4D.
(D) Relationship between levels of nuclear accumulation of pA+ RNA (x axis) and the mean of HSP104 and SSA4 RNA expression (y axis) in the indicated mutants strains relative to the WT control. Single repeats for each strain are shown separately. The mean of replicates from the individual strains is indicated and labeled and a power function has been fitted to the dataset.
See also Figure S3.
Figure 4Nab2p Is Sequestered on Nuclear-Retained RNA in Export-Deficient Cells and Excess Nab2p Can Alleviate mRNA Downregulation
(A) SDS-PAGE of eluted samples from an RNA immunoprecipitation (IP) experiment in which endogenous Nab2p was immunoprecipitated from Mex67-AA cells without (“rapamycin –”) or treated with rapamycin for 30 min (“rapamycin +”). Before RNA IP, cells were not subjected to crosslinking (“0 J/cm2”), moderately cross-linked (“300 J/cm2,” ∼2 min cross-linking time), or strongly cross-linked (“700 J/cm2,” ∼5 min cross-linking time). Mock samples were negative control IPs using beads without anti-Nab2p antibody. Shown are IP eluates without (lanes 1–7) or with (lanes 8–14) prior RNaseA/T1 treatment. Top: western blotting analysis of Nab2p levels; bottom: autoradiogram of P32-labeled SDS-PAGE gel (representative example of three independent repeats).
(B) Quantification of the P32-labeled RNA signal from lanes 1–7 in (A). Background was estimated and subtracted on the basis of the mock sample. Single points represent values obtained from three individual repeats. Error bars represent SDs.
(C) Quantification of P32-labeled RNA signal within the Nab2p contained band of lanes 8–14 from (A). Values were normalized as in Figure 4B. Error bars represent SDs from three independent repeats, and statistical significance was tested using a two-tailed paired t test.
(D) RT-qPCR analysis of selected 10 min 4tU-labeled RNAs purified from cells treated for 15 min with rapamycin as in Figure 3C. RNA series 2–4 show new RNA production from control Mex67-AA cells grown in glucose (series 3), which have been simultaneously depleted for Nab2p (Mex67-AA/Nab2-AA) (series 2) or containing a Nab2p expressing plasmid (Mex67-AA p2μ_NAB2) (series 4). Values derive from a minimum of four biological replicates, and error bars indicate SDs. Values for RNA series 3 were also included in the mean shown in Figure 3C. RNA series 5–9 show new RNAs from Mex67-AA cells containing an empty (series 5) or a pPgal_Nab2 (series 6–9) plasmid and incubated for 2.5, 5, 6, or 8 hr in galactose. Values are a mean of two biological replicates for the pPgal_Nab2 containing samples and an average of single replicates of all galactose incubation times for the empty plasmid sample. Error bars indicate median absolute deviation.
(E) Western blotting analysis of Nab2p levels in non-rapamycin-treated Mex67-AA cells transformed with either an empty 2μ pRS426 plasmid (−) or its counterpart (pNAB2) expressing wild-type Nab2p (+). Rpb3p served as a loading control.
(F) Western blotting analysis showing Nab2p and Rpb3p levels in cells containing a NAB2 gene under control of a galactose-inducible promoter (pPgal_Nab2) in glucose (GLU) condition and at the indicated times after galactose (GAL) addition. The image was edited to show only one of the repeats performed in parallel.
See also Figure S4.
Figure 5Nuclear RNA Export Block Sequesters Nab2p on Retained RNAs and Elicits the Decay of Newly Made Transcripts
Model for the decay of newly synthesized pA+ RNA in export compromised cells. In normal conditions (“WT”), Nab2p protects newly made transcripts and stimulates Mex67p-mediated nuclear export (top). When pA+ RNA export is compromised (“EXPORT BLOCK”), Nab2p is inactivated, likely by getting sequestered on retained pA+ RNA (bottom left). Hence, Nab2p is unavailable to protect newly made transcripts, leading to their decay, similarly to conditions of Nab2p nuclear depletion (bottom right).
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| anti-Rpb3p | Abcam | 1Y26 cat. no.: ab81859; RRID: |
| anti-Nab2p | 3F2 | |
| Alexa Fluor 488-labeled goat anti-mouse IgG | Invitrogen | Cat. no.: A32723; RRID: |
| anti-Pab1 1G1 | Santa Cruz | Cat. no.: sc57953; RRID: |
| anti-Rrp6 | Jensen group | Production bleed AAU1 |
| Auxin (Indole-3-acetic acid sodium salt) | Sigma Aldrich | Cat. no.: 15148-10G |
| MTSEA-biotin | Biotium | Cat. no.: 90064 |
| ProlongGold with DAPI solution | Life Technologies | Cat. no.: P36935 |
| Rapamycin | Cayman chemicals | Cat. no.: 13346 |
| 4tU | Aldrich | Cat. no.: 440736-1G |
| Turbo DNase free kit | Ambion | Cat. no.: AM1907M |
| SuperScript II | Invitrogen | Cat. no.: 18064-014 |
| Platinum SYBR Green qPCR Super-Mix-UDG kit | Invitrogen | Cat. no.: 11733-046 |
| ThermoFisher | Cat. no.: AM1350 | |
| PureLink micro RNA purification kit | Ambion | Cat. no.: 12183018A |
| Ribo-Zero Gold rRNA Removal kit for yeast | Ilumina | Cat. No.: MRZY1306 |
| RiboLock Rnase Inhibitor | ThermoSceintific | Cat. no.: E00381 |
| Lexogen QuantSeq 3′ mRNA-Seq Library Prep Kit REV | Lexogen | Cat. no.: 016.96 |
| RNase A/T1 | Thermo Scientific | Cat. no. EN0551 |
| PNK enzyme with buffer A | Thermo Scientific | Cat. no.: EK0031 |
| 10 min 4tU | This study | GEO: |
| 2 min 4tU | This study | GEO: |
| Raw data for all figures | This study | |
| N/A | UCSC: sacCer3 | |
| N/A | ENSEMBL: EF2 | |
| This study | ||
| This study | ||
| This study | ||
| This study | ||
| This study | ||
| This study | ||
| This study | ||
| This study | ||
| This study | ||
| This study | ||
| See | N/A | N/A |
| 2μ, ori(f1), ori(pMB1), URA3, Ampr, LacZ, MCS, T7 promoter, T3 promoter | ATCC 77107 | pRS426 |
| 2μ, ori(f1), ori(pMB1), URA3, Ampr, LacZ, MCS, T7 promoter, T3 promoter, NAB2 in KpnI-XhoI | PAC717 kind gift from A. Corbett | pRS246-NAB2 |
| 2μ, ori(f1), ori(pMB1), URA3, Ampr, LacZ, MCS, T7 promoter, T3 promoter, FUI1 | p4FUI(URA) | |
| 2μ, ori(f1), ori(pUC), URA3, Ampr, T | Stratagene | pESC_URA |
| 2μ, ori(f1), ori(pUC), URA3, Ampr, T | This work | p |
| ImageJ | N/A | |
| DAPI area selection macro for ImageJ | This study | N/A |
| BBMAP v 35.92 | unpublished | |
| STAR aligner v GitHub 2016-03-14 | ||
| samtools v 1.3 | ||
| HTSeq v 0.6.0 | ||
| R package DESeq2 v 1.10.1 | ||
| deepTools2 software suite v2.2.4 | ||
| GitHub | N/A | |
| Aria MX Real Time PCR System | Agilent Technologies | Cat. no.: G8830A |
| Axiovert 200M microscope Cy3, DAPI, FITC filters | Zeiss | N/A |
| Covaris S2 Focused Ultrasonicator | Covaris | N/A |
| Bioanalyzer | Agilent | N/A |
| Dynabeads M280 Sheep anti-mouse IgG | Invitrogen | Cat. no.: 11202D |
| Dynabeads MyOne Streptavidin C1 | Invitrogen | Cat. no.: 65002 |
| MG-SR PLUS X-ray films | Konica Minolta | Cat. no.: A3WM |
| NuPAGE 4-12% Bis-Tris Protein Gels | ThermoFisher Scientific | Cat. no.: NP0322BOX |
| NuPage 4x loading dye | Thermo Fisher | Cat. no. NP0007 |
| Typhoon FLA9500 | GeHealthcare | Cat. no.: 28996943 |
| UV Stratalinker 1800 | Stratagene | N/A |
| Zeba Spin Desalting Columns 7KMWCO | Thermo Scientific | Cat. no.: 89890 |
| 3-8% Tris acetate gel | Invitrogen | Cat. no.: EA03755BOX |
| RNAPII ChIP-tiling array | ArrayExpress | |
| RNAPII ChIP-seq | sample GSM2551210 from GEO: | |
| NETseq | sample GSM617027 from GEO: | |
| RNAPII CRAC | sample GSM1706520 from GEO: | |
| cDTA | ArrayExpress: | |
| DTA | ArrayExpress: | |
| GEO: | ||